Lumida
/AVD
⌘K
American Vanguard Corp

American Vanguard Corp

AVD
$2.26USD↑+1.35%+0.03 today

MARKET CAP

66.7M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$2 – $2

52W RANGE

$2
$6

AI Summary

Stalk
TrimMedium

AVD remains in an early Stage 1 consolidation after a steep decline, with intermediate resistance forming at flattening EMAs and a declining 200 DMA. Medium-term bias stays bearish on the lower-high structure, while short-term timing is neutral. Defer selling into the $2.90–3.00 zone on rejections at the 9/20 EMA or 50 SMA. A decisive break below the EMA zone would trigger accelerated bearish risk and invalidate the current setup.

  • ↑U.S. sales +6% in H1 2026 driven by herbicides and insecticides.
  • ↑Adjusted EBITDA +350% to $8.2M in Q3 2025 on volume and margin gains.
  • ↓International revenue -18% in Q2 2026 amid Brazil and India headwinds.
Full analysis →

Buying

5

institutions

Selling

2

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

SELL933.47 K2.61 M+-1.15 M-49.5%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY372.76 K1.04 M+205.26 K+150.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY355.28 K994.78 K+136.98 K+83.0%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW202.52 K567.07 K+202.52 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL183.47 K497.20 K+-345.72 K-62.9%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY105.38 K295.06 K+15.90 K+32.4%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW59.36 K166.21 K+59.36 K+0.0%0.00%